Thursday, August 25, 2016 1:43:14 PM
As I said earlier, the BIEL financing model was very creative, and, successful! I will say no more - combine that testimony with the details of the financing model, do the hard work of interpretation and I assure you you will smile and say holyyyyy . . . . If she stepped over a line, there should and will be sanctions, if she didn't, there won't.
The fact remains, BIEL was very successfully financed for years, rather than throwing in the towel and quitting. Marines don't do that, so well done BIEL, my investment is safe and FDA OTC clearance for ActiPatch is imminent . . . soon . . . semper fi . . . .thank you Whelans for persevering . . . .
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM